Earnings Summary

Wave Life Sciences Ltd’s revenue jumped 2245.12% since last year same period to $29.06Mn in the Q4 2023. On a quarterly growth basis, Wave Life Sciences Ltd has generated -40.96% fall in its revenue since last 3-months.

Wave Life Sciences Ltd’s net profit jumped 62.81% since last year same period to $-16.26Mn in the Q4 2023. On a quarterly growth basis, Wave Life Sciences Ltd has generated -324.16% fall in its net profits since last 3-months.

Wave Life Sciences Ltd’s net profit margin jumped 98.41% since last year same period to -55.95% in the Q4 2023. On a quarterly growth basis, Wave Life Sciences Ltd has generated -479.67% fall in its net profit margins since last 3-months.

Wave Life Sciences Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.21 - a 8.7% jump from last quarter’s estimates.

Wave Life Sciences Ltd’s earning per share (EPS) estimates for the current year stand at -0.21.

Wave Life Sciences Ltd’s earning per share (EPS) jumped 68.09% since last year same period to -0.15 in the Q4 2023. This indicates that the Wave Life Sciences Ltd has generated 68.09% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Wave Life Sciences Ltd’s return on assets (ROA) stands at -0.2.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Wave Life Sciences Ltd’s return on equity (ROE) stands at -11.18.